Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 2470 participants.

Also called NCT02508714

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 2,470 participants (enrolled count) (from the registry)
Sponsor
Thorax Centrum Twente (from the registry)
Registry
  • NCT NCT02508714
Other papers using this trial's data
  • Elderly patients treated with Onyx versus Orsiro drug-eluting coronary stents in a randomized clinical trial with long-term follow-up Clinical research in cardiology : official journal of the German Cardiac Society, 2025-12 DOI, PubMed 40035811, PMC12708834 In the PMC Open Access subset under CC BY.
  • Final 5-year report of BIONYX comparing the thin-composite wire-strut zotarolimus-eluting stent versus ultrathin-strut sirolimus-eluting stent Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2024-07 DOI, PubMed 38713843
  • First Report of 3-Year Clinical Outcome After Treatment With Novel Resolute Onyx Stents in the Randomized BIONYX Trial Circulation journal : official journal of the Japanese Circulation Society, 2021-10-25 DOI, PubMed 34261828
  • Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt-chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial Lancet (London, England), 2018-10-06 DOI, PubMed 30253879

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Belgium, Israel, Netherlands (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02508714. Randomized; double masking; primary purpose treatment. Start 2016-10-07 (actual); primary completion 2018-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents
Acronym
BIONYX
Condition
Angina Pectoris
Condition
Unstable Angina Pectoris
Condition
Acute Coronary Syndrome
Condition
Coronary Stenosis
Condition
Coronary Restenosis
Intervention (Device)
Orsiro
Intervention (Device)
Resolute Onyx
Lead sponsor
Thorax Centrum Twente (class: other)

Record details

Record id
cardio:ct-nct02508714
Content hash
7cd79b85e6c682c5a65d47696119eec874f711d2e379e6430b1bbbe954482086